Acute lymphoblastic leukemia in children with Down syndrome: a retrospective analysis from the Ponte di Legno study group
Trudy Buitenkamp(Erasmus MC - Sophia Children’s Hospital), C. Michel Zwaan(Princess Máxima Center), Hélène Cavé(Hôpital Robert-Debré), Ithamar Ganmore(Tel Aviv University), Tim Lammens(Ghent University Hospital), Georg Mann(St Anna Children's Hospital), Ching‐Hon Pui(St. Jude Children's Research Hospital), Keizo Horibe(National Hospital Organization), Martin Schrappe(University Hospital Schleswig-Holstein), Gabriele Escherich(Universität Hamburg), Stephen P. Hunger(Children's Hospital of Philadelphia), Shai Izraeli(Tel Aviv University), Maria Morak(St Anna Children's Hospital), Anthony V. Moorman(Newcastle University), Rob Pieters(Princess Máxima Center), Marry M. van den Heuvel‐Eibrink(Princess Máxima Center), Gunnar Cario, Atsushi Manabe(St. Luke's International Hospital), Charles G. Mullighan(St. Jude Children's Research Hospital), Lewis B. Silverman(Columbia University Irving Medical Center), Andrea Biondi(University of Milano-Bicocca), Giuseppe Basso(University of Padua), Jerzy Kowalczyk(Poznan University of Medical Sciences), Veerle Mondelaers(Ghent University Hospital), C Korbijn(Stichting Kinderoncologie Nederland), Ajay Vora(Great Ormond Street Hospital), Maurizio Aricò(University of Bari Aldo Moro), Kjeld Schmiegelow(University of Copenhagen), James A. Whitlock(Hospital for Sick Children), Der-Cheng Liang(Mackay Memorial Hospital), Nyla A. Heerema(The Ohio State University), Batia Stark(Schneider Children's Medical Center), Martin Zimmermann(Stichting Kinderoncologie Nederland), Erik Forestier(Erasmus MC), Renate Panzer‐Grümayer(St Anna Children's Hospital), K R Rabin(Baylor College of Medicine)
Cited by 248
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia
|Journal of Clinical Oncology|2003|2.7k
Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2013|2.2k
Treatment of Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2006|2k